Présentation
Review of Existing Evidence on Single-Dose HPV Vaccination
Overview of evidence for decision making on single dose HPV schedules
Auteurs
Langues
Année de publication
2022
Type
Présentation
Catégories
- Données
Maladies
- Papillomavirus humain
Organisations
- PATH
HPV-INTRO-SINGLE
| Titre | Auteur | Année | Type | Langue |
|---|---|---|---|---|
| Review of Existing Evidence on Single-Dose HPV Vaccination | Single dose consortium | 2022 | Presentation | Anglais, Français |
| HPV VACCINE SCHEDULE OPTIMIZATION Key considerations for decision-making, planning, and implementation | PATH, JSI, UNICEF, Gavi, the Vaccine Alliance, Clinton Health Access Initiative (CHAI), Jhpiego, International Vaccine Access Center (IVAC), Centers for Disease Control and Prevention (CDC), John Hopkins Bloomberg School of Public Health | 2023 | Guidance | Anglais, Français, Portuguais, Russe, Espagnol |
| Considerations for Human Papillomavirus (HPV) Vaccine Product Choice: Second Edition | World Health Organization (WHO) | 2024 | Guidance | Anglais |
| The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands | PATH | 2025 | Report | Anglais |
